|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 1.985 USD | -0.75% |
|
-2.22% | +44.89% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-12 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Chart calendar Allogene Therapeutics, Inc.
Upcoming events on Allogene Therapeutics, Inc.
No events available
Past events on Allogene Therapeutics, Inc.
| 2026-08-12 | Earnings release - Q2 2026 | |
| 2026-08-12 | Earnings presentation | 17:00 |
| 2026-06-18 | Annual General Meeting | 11:00 |
| 2026-06-18 | Présentation aux Actionnaires / Analystes | 11:00 |
| 2026-05-13 | Earnings presentation | 17:00 |
| 2026-05-13 | Earnings release - Q1 2026 | |
| 2026-04-13 | Information meeting | 08:30 |
| 2026-03-12 | Earnings presentation | 17:00 |
| 2026-03-12 | Earnings release - Q4 2025 | |
| 2025-11-06 | Earnings presentation | 17:00 |
| 2025-11-06 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,10 0,13 -28.76% | 0,02 0,03 -35.84% | 0,00 0,00 - | 3,40 | 12,1 | 84,6 |
|
EBITDA Million USD | Released Forecast Spread | -314 -294 -6.61% | -244 -266 8.35% | -197 -205 4.09% | -200 | -240 | -271 |
|
EBIT Million USD | Released Forecast Spread | -328 -321 -2.09% | -257 -283 9.03% | -209 -222 5.72% | -199 | -233 | -218 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -327 -315 -4.05% | -258 -267 3.44% | -191 -204 6.45% | -186 | -221 | -212 |
|
Net income Million USD | Released Forecast Spread | -327 -314 -4.38% | -258 -267 3.4% | -191 -203 6.13% | -185 | -220 | -212 |
|
EPS USD | Released Forecast Spread | -2,09 -2,02 -3.62% | -1,32 -1,36 3% | -0,87 -0,93 6.34% | -0,60 | -0,64 | -0,56 |
| Announcement Date | 14/03/24 | 13/03/25 | 12/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,01 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 109.01% | 0,00 | 0,00 | 0,00 | 0,00 | 0,01 | 1,16 |
|
EBITDA Million USD | Released Forecast Spread | -57,3 -64,6 11.42% | -62,1 -58,8 -5.67% | -53,7 -60,9 11.8% | -41,8 -54,4 23.13% | -39,3 -50,2 21.61% | -43,2 -43,2 0.02% | -44,3 -47,1 5.91% | -52,7 | -61,0 | -58,1 | -64,7 | ||
|
EBIT Million USD | Released Forecast Spread | -60,5 -72,9 17.06% | -65,2 -63,5 -2.66% | -56,8 -63,1 9.98% | -44,9 -52,7 14.84% | -42,4 -55,6 23.71% | -46,1 -46,3 0.56% | -46,9 -51,4 8.64% | -51,3 | -54,4 | -54,4 | -57,8 | -56,6 | -70,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -59,5 -70,5 15.6% | -59,7 -60,2 0.83% | -50,9 -59,4 14.22% | -41,4 -47,5 12.93% | -38,8 -50,5 23.16% | -42,6 -43,6 2.27% | -42,7 -47,6 10.41% | -48,6 | -51,3 | -48,4 | -50,6 | -52,7 | -62,2 |
|
Net income Million USD | Released Forecast Spread | -59,9 -70,5 14.97% | -59,7 -60,2 0.83% | -50,9 -59,4 14.22% | -41,4 -47,5 12.93% | -38,8 -50,5 23.16% | -42,6 -43,6 2.27% | -42,7 -47,6 10.41% | -48,6 | -51,3 | -48,4 | -50,6 | -52,7 | -62,2 |
|
EPS USD | Released Forecast Spread | -0,28 -0,33 15.6% | -0,28 -0,28 1.17% | -0,23 -0,28 16.44% | -0,19 -0,22 14.57% | -0,17 -0,22 21.71% | -0,18 -0,19 5.27% | -0,13 -0,17 23.48% | -0,15 | -0,15 | -0,15 | -0,16 | -0,15 | -0,17 |
| Announcement Date | 13/03/25 | 13/05/25 | 13/08/25 | 06/11/25 | 12/03/26 | 13/05/26 | 12/08/26 | - | - | - | - | - | - |
| Today |  | Earnings presentation | 22:00 |
| Today | | Ex-dividend date - 0.6 CNY | 00:00 |
| Today | | Information meeting | 08:00 |
| 2026-09-02 | | Information meeting | |
| 2026-09-04 | | Ex-dividend date - 0.51 CNY | 00:00 |
| 2026-09-04 | | Earnings presentation | 01:00 |
| 2026-09-08 | | Extraordinary General Meeting | 23:00 |
| 2026-09-08 | | Présentation aux Actionnaires / Analystes | 02:00 |
| 2026-09-10 | | Extraordinary General Meeting | 04:00 |
| 2026-09-16 | | Extraordinary General Meeting |
Past sector events for Allogene Therapeutics, Inc.
| 2026-09-01 | | Information meeting | 08:30 |
| 2026-08-31 | | Information meeting | 08:00 |
| 2026-08-31 | | Earnings release - Q2 2026 | |
| 2026-08-31 | | Earnings release - Q2 2026 | |
| 2026-08-29 | | Earnings release - Q2 2026 | |
| 2026-08-29 | | Board of Directors Meeting | |
| 2026-08-29 | | Earnings release - Q2 2026 | |
| 2026-08-28 | | Information meeting | 08:00 |
| 2026-08-28 | | Extraordinary General Meeting | 12:00 |
| 2026-08-28 | | Présentation aux Actionnaires / Analystes | 12:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
- Calendar Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
